| Literature DB >> 14684439 |
Carol A Tamminga1, Adrienne C Lahti, Deborah R Medoff, Xue-Min Gao, Henry H Holcomb.
Abstract
Our findings with schizophrenia and the glutamate system have relied on the characterization of the clinical response of patients to ketamine and their functional brain imaging response (rCBF) to the drug. Prior to the human studies reported here, we had evaluated the region activation characteristics and pharmacology of PCP and its congener MK 801 in animals. What I will report in this paper has been individually reported elsewhere but brought together here in a new synthesis.Entities:
Mesh：
Substances：
Year: 2003 PMID： 14684439 DOI： 10.1196/annals.1300.062
Source DB: PubMed Journal: Ann N Y Acad Sci ISSN： 0077-8923 Impact factor: 5.691